Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
Journal Information
Full Title: Blood Rev
Abbreviation: Blood Rev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of Competing Interest Kamran Shojania: Involved in investigator-initiated vasculitis study for Bristol-Myers-Squibb. Shahin Jamal: Attended Roche advisory board for tocilizumab in giant cell arteritis and rheumatoid arthritis. Kevin A. Hay: Attended Advisory boards and received honoraria for Celgene and Gilead related to CAR-T cell products. James T. England, Alym Abdulla, Ryan L. Hoiland, Cheryl L. Wellington, Mypinder Sekhon, Agnes Y.Y. Lee, Catherine Biggs, Luke Chen – no conflicts of interest to declare."
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025